ArticleFrontiers in pharmacology2023

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway.

Mingyue Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.